Butterbur for Allergies: Evidence and Safety

Butterbur (Petasites hybridus) is a marshland plant from the daisy family that has been used medicinally in Europe since the Middle Ages. Today it is one of the few herbal medicines to have demonstrated efficacy in randomized controlled trials against pharmaceutical antihistamines for seasonal allergic rhinitis—without the sedation that plagues many allergy medications. Understanding how butterbur works, why the PA-free requirement is non-negotiable, and how to use it properly can help allergy sufferers make an informed decision.

What Are Petasins?

The active compounds in butterbur are sesquiterpenes called petasins, specifically petasin and isopetasin. These compounds have two complementary anti-allergic mechanisms. First, they inhibit the enzyme 5-lipoxygenase (5-LOX), which is responsible for synthesizing leukotrienes—powerful inflammatory mediators that cause nasal congestion, bronchoconstriction, and mucus secretion. This is a similar mechanism to pharmaceutical leukotriene receptor antagonists like montelukast. Second, petasins inhibit platelet-activating factor (PAF), a pro-inflammatory phospholipid that triggers mast cell degranulation and amplifies allergic responses. The combination of leukotriene and PAF inhibition gives butterbur a more complete anti-allergic profile than antihistamines, which only block histamine but do not address leukotrienes or PAF.

The BMJ Clinical Trial: Ze339 vs. Cetirizine

The landmark study was a double-blind, randomized, parallel-group trial published in the BMJ (2002) by Schapowal and colleagues. Researchers compared butterbur extract Ze339 (one tablet four times daily, delivering 8 mg petasin per tablet) versus cetirizine (10 mg daily) in 125 patients with symptomatic seasonal allergic rhinitis. The result: butterbur Ze339 was therapeutically equivalent to cetirizine on total symptom score, quality of life measures, and patient global assessment—with no difference in efficacy. Critically, butterbur caused significantly less drowsiness than cetirizine. A follow-up trial by the same group confirmed these results in a larger cohort. A separate Cochrane-level systematic review concluded that butterbur has good evidence for efficacy in seasonal allergic rhinitis.

Additional Clinical Evidence

Beyond the cetirizine comparison, butterbur has been compared to fexofenadine (another non-sedating antihistamine) in rhinitis trials with similar findings of comparable efficacy. Studies specifically in patients with grass pollen and tree pollen allergies have shown consistent symptom reduction. Some research also shows benefit in asthma, with butterbur reducing leukotriene levels in airway secretions—a mechanism relevant to the allergic asthma phenotype where seasonal allergens trigger bronchospasm.

The Non-Negotiable: PA-Free Products Only

Here is the most important safety information about butterbur: the plant naturally contains pyrrolizidine alkaloids (PAs)—compounds that are hepatotoxic (liver-damaging) and potentially carcinogenic. Consuming raw butterbur root, unprocessed supplements, or products not specifically certified PA-free is dangerous and has caused cases of veno-occlusive liver disease. All clinical trials used PA-free standardized extracts, and regulatory agencies in Germany, Switzerland, and the UK specifically require PA-free labeling on butterbur products. When purchasing butterbur: look for products labeled PA-free, check for standardization to petasin/isopetasin content, and use established brands whose manufacturing process specifically removes PAs. The Swiss product Ze339 (sold as Petadolex in the US and UK) is the most thoroughly tested PA-free extract.

Dosing Protocols

The most studied dose is Ze339: one 50 mg tablet three to four times daily (equivalent to 8 mg petasin total per tablet) during allergy season. Generic equivalents typically recommend 50–75 mg of standardized PA-free extract twice daily. Unlike some supplements where starting several weeks early matters less, butterbur produces more consistent benefit when started 1–2 weeks before pollen season onset, allowing petasin levels to accumulate in tissues. Treatment duration is typically limited to the allergy season—safety data beyond 12–16 weeks of continuous use is limited, though some patients use it intermittently for perennial allergies.

Safety Profile and Side Effects

In PA-free form, butterbur has a good safety profile. The most commonly reported side effects in clinical trials are mild gastrointestinal symptoms—nausea, burping, and stomach upset—in less than 10% of users. These are reduced by taking butterbur with food. Headache has been reported in some users. Butterbur is a member of the Asteraceae (daisy) family; people with ragweed, chrysanthemum, or daisy allergies may experience cross-reactivity and should start with a small test dose under supervision. Butterbur is not recommended during pregnancy or breastfeeding due to insufficient safety data.

FAQ

Q: Is butterbur better than antihistamines for allergy congestion?

Butterbur may actually be superior for congestion because it inhibits leukotrienes—the primary driver of nasal congestion—which antihistamines do not target. For runny nose and sneezing, both are equally effective. For congestion, butterbur has an edge.

Q: Can children take butterbur?

Clinical trials have included children as young as 6 using Ze339 at lower doses with a favorable safety profile. However, pediatric dosing guidance is limited and should be discussed with a healthcare provider.

Q: How do I know if my butterbur is truly PA-free?

Look for products from established brands that publish third-party testing certificates. The Petadolex brand (Weber and Weber) tests each batch to below detectable limits for PAs. Unbranded or low-cost products from unknown manufacturers should be avoided.

Q: Can I take butterbur every allergy season year after year?

Long-term safety data for continuous use extends to about 16 weeks per year in clinical research. Using it seasonally with breaks appears safe based on available evidence, though very long-term (multi-year) data is not available.

Track your supplements in Optimize.